Replies to post #13769 on Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

Crickets !

Finally! Some discussion!

Point 1: Independently reviewed by who? Who made the decision to increase the sample size to try and find signal? The executives did. Why not start a new trial? They have chronic cough running, and if they believed Phase 3 covid had a chance, you would think they would focus on that. But what's most important as a red flag is the timing. They dropped prelim data news which was a flop, and shortly thereafter planned a new phase 1. thats the red flag. its classic, pump the SP up before dropping the final news (flop).

2. what you're proposing is that there be no accountability. are they free to pay themselves ANYTHING. They make zero profits, thus they should be paying themselves much less than they are (400k... are you kidding, with no revenues, using money they fundraised :O through dilution at YOUR expense...)

3. they have changed the number of patients in the data readout to find signal, and delayed the final results ... if the trial was completed before this fire, than why is the readout being delayed? Proof of the fire?

4. There's only so much time in the day. Running a pharma company takes A LOT of time. This further supports my point about the execs being over paid. You think mark williams deserves hundreds of thousands of dollars for working at Algernon making no revenue and also spending his time (what %?) at his own (separate) company?

5. You are speaking as a non-scientist. In science, if you say you will read out using x number of patients, and you manipulate that because x patients didn't find signal... that's unethical and simply a ref flag of whats to come in the final readout.

6. Dilute and dilute ... but the fact is that hitting the jackpot in penny land is rare and more likely you will be diluted to dirt. Most of us who have been around since breathtec understand, these guys dilute and dilute and have NEVER generated a single dollar... university of florida who?

7. I don't prefer pumping. I guess just compensating for no revenues and a flopped prelim data readout....